Meta's Facebook and Instagram platforms served thousands of advertisements promoting AI-powered 'nudify' apps, according to internal findings. The ads violated the company's own policies against nudity and sexual content, raising fresh questions about the effectiveness of its content moderation systems.
How the ads slipped through
Meta's advertising policies explicitly ban ads that depict nudity or sexual activity, as well as those that promote apps designed to create non-consensual intimate images. Yet the company's automated review systems allowed thousands of such ads to run. The apps in question use artificial intelligence to digitally remove clothing from photos, a practice critics call a form of image-based abuse. It's not clear how the ads evaded detection, but the scale suggests gaps in Meta's enforcement.
The scale of the problem
Internal data reviewed by the company showed that the ads were served across both Facebook and Instagram. The exact number wasn't disclosed, but sources described it as 'thousands.' The ads appeared in users' feeds and in Instagram Stories, often with suggestive language and images. Some of the ads were reported by users, but many remained live for days or weeks before being taken down.
Calls for regulation
The incident underscores the urgent need for stricter regulations and collaborative tech industry efforts to combat AI misuse. Without stronger guardrails, similar ads could continue to slip through. The problem isn't unique to Meta — other platforms have also struggled to police AI-generated content. But given Meta's size and its stated commitment to safety, the failure is particularly glaring. Advocacy groups have called for clearer rules on how platforms handle AI-generated material, especially when it involves non-consensual intimate imagery.
Meta has not publicly addressed the specific ads or outlined any changes to its ad review process. The company's automated systems are designed to catch policy violations, but this case shows they're far from foolproof. Whether Meta will face regulatory action remains an open question.
